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Six metabolites of Trequinsin [9,10-dimethoxy-3-methyl-2-(2,4,6-trimethylphenylimino-3,4,6, 7-
tetrahydro-2H-pyrimido[ 6, l-a]isoquinolin-4-one. hydrochloride] are identified which have been
synthesised from the parent molecule trequinsin 1. A base-promoted selective demethylation of 1 at
position 9 gives the metabolite 4. An acid aided demethylation at position 10 furnishes the metabolite 7.
Treatment of compounds 1 and 4 with DDQ gives the 4'-DDQ complexes 10 and 14 respectively. These
complexes on treatment with ZnCIz-MeOH afford the 4'-methoxymethyl derivatives 11 and 15
respectively, which on subsequent demethylation with dil. HCI give the corresponding hydroxy
derivatives 2 and 5. When treated with two equivalents of DDQ, 1 gives the DDQ complex 12, which on
subsequent treatment with Zn(OAc)z yields the 4'-formyl derivative 13. Oxidation of 13 with AgNOr
NaOH gives the 4'-carboxy derivative 3, which was subsequently selectively demethylated to give the
metabolite 6. Treatment of 13 with NHzOH.HCl produces the oxime 17, which is then dehydrated to the
nitrile 18 using (Ac)zO. Alkaline hydrolysis of 18 gives 3.
Trequinsin has been discovered by our group'< as a
powerful antihypertensive agent possessing
excellent platelet antiaggregation properties and
stands out as one of the most powerful
phosphodiesterase inhibitors. Several papers and a
review article3 have appeared on the molecule.
This compound reached the clinical trials! (phase
1). The isolation and identification of the six major
metabolites (2-7) (Scheme I) of trequinsin 1 have
been carried out at Hoechst Frankfurt",
Literature records several examples':", where all
the known (isolated) metabolites of a drug have
been synthesised using the regular synthetic
approaches. However, we have not come across
any report in the literature, of a drug, where all the
metabolites were prepared from the parent
compound. The biomimetic synthesis of the
Metabolites 2-7 has been carried out and forms the
subject matter of this paper. The uniqueness of the
synthesis is that all the metabolites were made
from trequinsin in a manner mimicking chemically
the biological pattern of metabolism. \ The
individual metabolically vulnerable centres of the
free base of trequinsin molecule 1 were targetted to
chemical sequences using specific reagents. The
substituents at positions 9 and 4' of 1 are the
centres more vulnerable to metabolic attack
followed by those at positions 10 and 3.
Results and Discussions
Methoxyl group at position 9 froms a part of the
highly extended conjugated system in 1 as
compared to the IO-methoxyl group. The 2'- and 6'-
methyl groups are sterically more crowded than the
4'-methyl group, which makes position 4', more
vulnerable to a chemical transformation. When the
lO-methoxy group is converted to the IO-hydroxy
group, position 7 of the molecule becomes electron
rich. However, no metabolite involving position 7
has been isolated from among the minor
unidentified metabolites of 1. After mapping out
the apparent differences in the electronic and
stereochemical centres of 1, a selection of the
correct reagents and reaction conditions led to the
synthesis of the desired metabolites.
Dernethylation of 1 using 65% AcOH-35% HBr
(48% aqueous)' gave the metabolites 7 and 4 (trace
amounts) together with the dihydroxy compound 9
(Scheme II). The structure of 7, was confirmed by
an unambiguous synthesis of the benzylated
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product of 7 viz compound 2S (Scheme III}. The
l O-hydroxy compound 7 was benzylated to give a
compound identical in all respects to compound 2S
proving that the assignment of 9-0H and 10-0H
groups to compounds 4 and 7 respectively is
correct.
Demethylation of 1 using pyridine hydrochloride
gave 8 in 65% yield. The 9-0CH3 group, which has
a lower electron density as compared to the 10-
OCH3 group, was demethylated to 4, using a basic
reagent ethylmercaptan-NaH-DMF8a,b , in low
yields. A replacement of DMF with HMP A gave 4
in 54% yield. An extension of this reaction to
metabolite 3, gave selectively the demethylated
metabolite 6 in 48% yield. Trequinsin 1 was also
demethylated without affecting the N-methyl group
Scheme I
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using 48% HBr to give 9. Metabolite 2 was
obtained by the selective demethylation of
compound 11 (4'-methoxymethyl derivative) using
2N-HCI, the rest of the methoxyls and methyl
groups remained unaffected.
In an earlier paper" the synthesis of an
intermediate of one of the major metabolites of 1
using DDQ has been reported. In continuation,
herein, the synthesis and reactions of some of the
other metabolites are reported. It should be noted
that the positions 7 and 4' of the trequinsin
molecule are the most likely to be oxidised. The
important prerequisite for benzylic oxidation
postulated 10, was the formation, with proper
orientation, of a charge transfer complex. In order
to oxidise position 7 of trequinsin, it was necessary
















to demethylate 10-methoxy group to the 10-
hydroxy metabolite 7.
As reported in the literature II, dihydro-
isoquinoline undergoes benzylic oxidation using
DDQ-MeOH via a methoxylate intermediate,
which on thermolytic elimination yields
isoquinoline. Extension of this observation to
metabolite 7, using benzene instead of MeOH gave
us 16 directly, involving no methoxylated
intermediate. In 1 the 4'-methyl group is activated
due to the effect of extended conjugation and is
susceptible to oxidation using DDQ. On
investigating this reaction, it was found that the 4'-
methyl group was selectively oxidised, using 1
equivalent of DDQ, to benzylic alcohol 2 (a major
metabolite) in low yields, the major product being
the DDQ complex 10. Cleavage of the complex 10
using ZnCh-MeOH gave the 4'-methoxy methyl
compound 11' in 33% yield, which was then
selectively demethylated using 2N HCI to obtain 2.
To increase the yields of 2, an attempt was first
made to breakup the complex 10 using PTSA-
methanol, however 11 and traces of the aldehyde
13 were obtained. BF3-etherate, silica gel, HCl and
sulfuric acid were also used to breakup 10, but the
anhydrous ZnCh-methanol combination proved to
be the most effective agent (Scheme IV).
It was postulated that with two equivalents of
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i. PhCHzBr,CHa0Na ii, CH3NOz' CH3COONH., CHaCOOH iii, NaBH.,aq MeOH,RT.
iv. AllHg, THF-HzO-MeOH. v. KCNO,AcOH, vi. CHz(COOEt)z,EtONa_ vii. POCla.
viii. mesitylamine ix. CH3I,KzC03,CH3COCH3' x. PHCHzBr,KzCOa,CHaCOCHa'
DDQ, 1 should get oxidised to the aldehyde 13. On
investigating the reaction, it was found that the
complex 12 was obtained, which was subsequently
cleaved using zinc acetate-dioxane to obtain 13.
However, oxidation of the metabolite 2 using
pyridinium chlorochromate gave 13 in higher
yields. Oxidation of the 9-hydroxy metabolite 4
with two equivalents of DDQ resulted in the
formation of the complex 14, which was
subsequently cleaved with ZnCh-MeOH to obtain
the methyl ether 15 and not an aldehyde. The
cleavage of the methoxyl group in 15 was achieved
using 2N HCI to give 5.
Among the many methods12-20 reported in the
literature, the one using AgN0320 in 50% aqueous
ethanol and NaOH as oxidising agent helped in the
conversion of 13 into the metabolite 3 in 28%
Stheme III
yield. Alternatively 13 was first converted into its
aldoxime 17 using hydroxylamine hydrochloride"
in pyridine-ethanol. The aldoxime 17 was then
easily dehydrated to the nitrile 18 with acetic
anhydride. Hydrolysis of 18 with 20% NaOH-
rectified spirit gave 3 (Scheme IV).
Conclusion
We have succeeded in generating
"chemometabolites" (degradation) of Trequinsin,
which parallels the actual metabolites in the
biological systems (All the metabolites of
trequinsin have been successfully synthesised from
the parent molecule trequinsin itself); and in the
process discovered (i) that the DDQ complex of
the metabolites can be broken using ZnCh-MeOH
to the methyl ethers, and (ii) that the bis complex
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of DDQ could be cleaved using Zn(OAc)2 to obtain
an aldehyde.
Experimental Section
General. Melting points were determined using
a Kotler hot stage apparatus and are uncorrected.
IH NMR spectra were recorded on a Varian T-60
or JEOL FX-90Q spectrometers, IR spectra on a
Perkin-Elmer 157 spectrophotometer using KBr
discs, and UV spectra (:>n a Carl Zeiss Specord
spectrophotometer using MeOH and MeOH-
NaOAc (Amax in nanometers).
9, I O-Dimethoxy-2- (2,6-dimethyl-4-hydroxy-
methyl-phenylimino-3-methyl-3,4,6,7-tetrahydro-
2H-pyrimido[6,I-a]isoquinolin-4-one 2. A solu-
tion oftrequinsin I (free base) (6.06 g, 15 mmoles)
and DDQ (3.41 g, 15 mmoles) in benzene (200
mL) was retluxed for 39 hr. Benzene was removed
under vacuo and the solid (lOg) obtained was
purified over a column of neutral alumina to obtain
0.8 g of a mixture of three compounds. This
mixture was rechromatographed to obtain the
desired product, which was crystallised from
CHCh-pet. ether (60-80°), yield 0.166 g (2%), m.p.
246-48°;. IR(KBr): 3333, 1692 em"; IH NMR
(CDCh): 8 2.07 (s, 6H, 2'-, and 6'-CH3), 1.93 (s,
I.H, OH), 2.9 (t, J=6 Hz, 2H, -CH2CH2N), 3.6 (s,
3H, NCH3), 3.4 (s, 3H, 10-OCH3), 3.9 (s, 3H, 9-
OCH3); 4.07 (t, J=6 Hz, 2H, -CH2CH2N), 4.6 (s,
2H, 4'-CH20-), 5.5 (s, IH, H-I), 6.73, (d, J=4 Hz,
2H, Ar-H). Anal. Found: C, 68.25; H, 5.97; N,





A: Compound 13 (0.5 g, 1.19 mmoles) was added
to a mixture of AgN03 (1.8 g, 10.6 mmoles) and
NaOH (0.8 g, 20 mmoles) in 30% aqueous
C2H50H(30 mL) and the reaction mixture retluxed
for 45 hr and neutralised with CH3COOH. The
organic solvent was removed under vacuo, and the
residue obtained purified by chromatography over
a silica gel column to give 3, yield: 0.146 g (28%).
Procedure B: Compound 18 (1.1 g, 2.7 mmoles
was retluxed in a mixture of 20% aqueous NaOH
(2 mL, 0.1 mole) and rectified spirit (40 mL) for
39 hr. The organic solvent was removed under
vacuo, water added, the solution chilled,
neutralised with AcOH and extracted with EtOAc.
The organic extract was washed with water, dried
(Na2S04) and the solvent removed under vacuo to
obtain the desired solid product which was
crystallised from chloroform-pet. Ether (60-80°),
yield 0.620 g (53.91%), m.p. 248-50°; IR(KBr):
3570, 2700-2500, 1692, 1639 cm"; IH NMR
(CDCb): 8 2.15 (s, 6H, 2'- and 6'-CH3), 2.87 (t,
J=6 Hz, 2H, -CH2CH2N), 3.6 (s, 3H, NCH3), 3.73
(s, 3H, 10-0CH3), 3.87 (s, 3H, 9-0CH3), 4.07 (t,
J=6 Hz, 2H, -CH2CH2N), 5.33 (s, IH, H-I), 6.63
(d, 2H, Ar-H), 7.77 (s, 2H, Ar-H), 7.2-7.4 (IH, br,
hump, OH, exchangeable with D20), Anal. Found:
C, 66.53; H, 6.28; N, 9.78. Calcd for C24H25N30S:
C, 66.20; H, 5.79; N, 9.65%.
9-Hydroxy-IO-methoxy-2-mesitylimino-3-methyl-
3,4,6,7 -tetrahydro-2H-pyrimido[ 6,1-0] isoquinolin-
4-one 4. Sodium hydride (2g; 60% dispersion in oil,
50.0 mmoles) was washed with dry benzene, then
taken in HMPA (5 mL) in an atmosphere of
nitrogen, and chilled. Ethanethiol (10.8 mL, 10.8
mmoles) was added dropwise, and the mixture
stirred for 5 min. Compound I (1.0 g, 2.5 mmoles)
was then added and the mixture stirred at room
temperature for 1.5 hr. The reaction mixture was
chilled, treated with methanol, water, extracted
with EtOAc, dried and concentrated to obtain 678
mg of the crude product, which was purified over a
column of basic alumina and crystallised from
EtOAc. Yield: 522 mg (54%) m.p. 256-58°. UV
(MeOH): 230 and 350 nm, UV (MeOH-NaOAc):
350nm; lR(KBr): 3448, 1678 em"; IH NMR
(CDCb): 8 2.03 (s, 6 H, 2'-,6'-CHJ), 2.27(s, 3H, 4'-
CH3), 2.8 (t, J=6 Hz, 2H, -CH2CH2N), 3.57 (s, 311
NCH3), 3.73 (s, 3 H, 0-CH3), 4.0 (I, J=6 Hz, 2H,
CH2CH2N), 5.4 (s, 1H, H-I), 6.67 (s, 2H, Ar-H),
6.8 (s, 2H, Ar-H). Anal. Found: C, 70.61; H, 6.25;





pound IS (1.112 g, 2.6 mmoles) was heated in 2N
HCI (56 mL) at 90-100°C for 93 hr. The reaction
mixture was chilled, basified with liquor NH;.
filtered and the filtrate extracted with CHCI3. The
CHCh extract was washed with water, dried
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(Na2S04) and concentrated under vacuo to obtain a
crude solid, which was purified over a column of
silica gel and crystallised from EtOH, yield: 0.56 g
(52.9%). m.p. 246-48°; IR(KBr): 3175-2985, 1721
em"; IH NMR (DMSO-d6): 02.03 (s, 6H, 2'-and 6'-
CH3), 2.83 (I, J=6 Hz, 2H, -CH1CH2N), 3.47 (s,
3H, NCH3), 3.65 (s, 3H, 10 -OCH3), 3.92 (I, J=6
Hz, 2H, -CH2CH1N), 4.43 (s, 2H, CH20H), 5.32
(s, IH, H-l), 6.70 (d, 2H, Ar-H), 6.98 (s, 2H, Ar-
H). Anal Found: C, 67.43; H, 6.06; N, 10.33. Calcd
for C23H25N304: C, 67.80; H,6. 19;N, 10.33%.
9-Hydroxy-lO-metboxy-2-(2,6-dimetbYI-4-car-
boxy)pbenylimino-3-methyl-3,4,6,7 -tetrabydro-
2H-pyrimido[6,I-a]isoquinolin-4-one 6. NaH (2
g, 50 mmoles, 60% dispersion in oil) was washed
with dry benzene and taken in HMPA (5 mL) in an
atmosphere of nitrogen and chilled. Ethanethiol
(10 mL, 0.135 moles) was added dropwise and the
mixture stirred for 5 min. Compound 3 (1.0 g, 2.3
mmoles) was then added in one lot and the mixture
stirred at room temperature for 23 hr. After usual
workup, the crude obtained was purified over a
column of silica gel, yield 0.472 g (48.76%). m.p.
314-15°. IR(KBr): 3448, 1695, 1639 em"; IH NMR
(Pyridine-de) 8 2.25 (s, 6H, 2'- and 6'-CH3),2.73 (I,
J=6 Hz, 2H, -CH2CH2N), 3.38 (3 H, s, NCH3),
(s, 3H, 10-0CH3). 4.07 (2H, t, J=6 Hz,
1 ,. "
-CH2CH2N), •5.73 (s, IH, H-l), 7.13 (s, 2H, Ar-H),
7.48 (s, 1H, Ar-8H), 8.17 (s, IH, Ar-ll H); Anal.
Found: C, 65.26; H, 5.29; N, 10.34. Calcd for
C23H23N30S: C, 65.55; H, 5.50; N, 9.97%.
100Hydroxy-9-metboxy-2-mesitylimino-3-metbyl-
3,4,6,7-tetrabydro-2H-pyrimido[ 6,I-a]isoquino-
Iin-4-ooe 7. Compound 1 (52.98 g, 12 moles) was
heated in a solution of acetic acid (693 mL, 12.12
moles) and 47% HBr (375 mL, 3.22 moles) at
115°C for 3 hr. Acetic acid was distilled off under
vacuo and the residue obtained was chilled, and
basified with liquor NH3 to obtain a yellow solid,
~hich in turn was washed with water, dried
(Na2S04) and purified by chromatography over
florisil to obtain a solid, which was crystallised
from Cl-lClj-pet. Ether (60-80°), yield 22.8 g
(48.59%), m.p. 245-47°; UV A(MeOH): 230 and
350 nm, UV(MeOH-NaOAc): 230 and 350 nm;
IR(KBr): 3390,1667 cm"; IH NMR (CDCh): 02.0
(s, 6H, 2'- and 6'-CH3), 2.27 (s, 3H, 4'-CH3), 2.83
(t, J=6 Hz, 2H, -CH2CH2N), 3.57 (s, 3H, NCH3),
3.87 (s, 3H, O-CH3), 4.03 (t, J=6 Hz, 2H, -
CH2CH2N), 5.47 (s, IH, H-l), 6.6 (s, IH, Ar-H),
6.83 (s, 3H, Ar-H). Anal. Found: C, 70.29; H, 6.39;




1 (1.0 g, 2.47 mmoles) was refluxed with pyridine
hydrochloride (lOg, 87 mmoles) for 20 min. The
reaction mixture was cooled, and treated with
chilled water to obtain a clear solution. The desired
product that separated out was crystallised from
DMF-H20, yield 0.59 g (65.85%). m.p. 280° (dec);
IR(KBr): 3333, 3030, 1639, and 1282 em" ; IH
NMR (DMSO): 8 2.13 (s, 6H, 2'- and 6'-CH3),2.27
(s, 3H, 4'-CH3), 2.8(t, J=6 Hz, 2H, -CH2CH2N),
3.87(t, J=6 Hz, 2H, -CH2CH2N), 5.2 (s, IH, H-I),
6.57-7 (m, 4H, Ar-H); Anal. Found: C, 68.01; H,




Tequinsin 1 (0.5 g, 1.23 mmoles) was refluxed in
48% aqueous HBr (5 mL) for 2 hr to obtain colorless
crystals, which were filtered, washed with water,
dried (Na2S04) and crystallised from methanol to
give 9, yield 0.356 g (63.01%). m.p. 300-302°;.
IR(KBr): 3125, 1721 ern"; IH NMR (DMSO): 8
1.9 (s, 6H, 2'- and 6'-CH3), 2.17 (s, 3H, 4'-CH3),
2.67 (I, J=6 Hz, 2H, -CH2CH2N), 3.33 (s, 3H,
NCH3), 3.77 (t, J=6 Hz, 2H, -CH2~H2N), 5.03 (s,
IH, H-I), 6.38 (s, 2H Ar-H), 6.57 (s, 2H, Ar-H).
Anal. Found: C, 57.70; H, 5.09; N, 9.31; Br, 17.25.





pound 1 (20 g, 0:049 moles) was taken in benzene
(600 mL) and DDQ (11.3 g, 0.049 mole) added to
it slowly with stirring. The reaction mixture was
refluxed for 20 hr and the organic solvent removed
10 (30.56 g) under vacuo to obtain a crude solid.
Titration of the solid with pet. ether yielded a
I: 1 complex of I-DDQ (30.56 g). This complex
(0.048 moles) was taken in dry methanol (1 L) to
which was added fused and powderedZnCh (52g,
0.382 mole), and the mixture refluxed for 43 hr.
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The solvent was removed under vacuo and the
residue obtained was treated with chilled water,
basified with 30% NaOH and extracted with
CHCh. The extract was washed with water, dried
(Na2S04)and the organic solvent removed under
vacuo to obtain the desired product which was
purified over a column of silica gel and crystallised
from EtOH-pet. ether, yield: 6.95 g (32.3%), m.p.
160-62°; IR(KBr): 1700 ern"; IH NMR (CDCh): 0
2.1 (s, 6H, 2'- and 6'-CH3), 2.88 (t, J=6 Hz, 2H, -
CH2CH2N), 3.37(s, 3H, -CH20CH3), 3.6(s, 3H,
NCH3), 3.73(s, 3H, 10-OCH3), 3.87(s, 3H, 9-
OCH3), 4.07(t, J=6 Hz, 2H, -CH2CH2N), 4.37 (s,
2H, CH20CH3), 5.43 (s, IH, H-l), 6.67 (d, J=4 Hz,
IH, Ar-H), 7.02 (s, 2H, Ar-H); Anal. Found: C,
65.26; H, 5.29; N, 10.34. Calcd. For C25H29N304:C,
65.55; H, 5.50; N, 9.97%.
9,10-dimethoxy-2-(2,6-dimethyl-4-formyl)-
phenylimino-3-methyl-3,4,6,7-tetrahydro-lH-pyri-
mido[6,1-a]isoquinolin-4-0ne 13. Procedure A.
Compound 1 (6.06 g, 0.015 ·mole) was taken in
benzene (200 mL) and DDQ (6.81 g, 0.03 mole)
added to it slowly with stirring. The reaction
mixture was refluxed for 43 hr and the organic
solvent subsequently removed under vacuo to
obtain a crude solid. Trituration of the solid with
pet. ether yielded a 1:2 complex 12 (12.8 g) of 1-
JDQ. This complex (5 g, 0.005 mole) was taken in
dioxane (200 mL) to which was added Zn(OAc)2
(10.0 g, 0.05 mole), and the mixture refluxed for
43 hr. and filtered.The filtrate was removed under
vacuo to obtain the desired product which was
purified over a column of silica gel and crystallised
from CH2Ch-EtOH, yield 0.5 g (8.3%). m.p. 241-
43°C. IR(KBr): 2941, 2857, 2717, 1709-1695,
1642 em"; IH NMR (CDCI3): 02.13 (s, 6H, 2' and
6'-CH3), 2.88 (t, J=6 Hz, 2H, -CH2CH2N), 3.57 (s,
3H, NCH3), 3.72 (s, 3H, 10-0CH3), 3.85 (s, 3H, 9-
OCH3), 4.05 (t, J=6 Hz, 2H, -CH2CH2N), 5.28 (s,
IH, H-l), 6.62 (s, 2H, Ar-H), 7.52 (s, 2H, Ar-H),
9.0 (s, IH, CHO); Anal. Found: C, 69.32; H, 6.42;
N, 10.25. Calcd for C24H25N304: C, 68.73; H, 6.01;
N, .10.02%.
Procedure B: To a suspension of pyridinium
chlorochromate(4.025 g, 18.7 mmoles) in CH2Ch
was added a CH2Ch solution of 2 (5.25 g, 12.47
mmoles) in one lot and the reaction mixture stirred
at room temperature for 2 hr. The organic solvent
was removed under vacuo and the crude obtained





Compound 4 (5.055 g, 0.013 mole) was taken in
benzene (300 mL) and DDQ (5.68 g, 0.025 mole)
added to it slowly with stirring. The reaction
mixture was refluxed for 20 hr and the organic
solvent removed under vacuo to obtain a crude
solid. Trituration of the solid with pet. ether
yielded a 1:2 complex 14 (30.56 g) of 4-DDQ. This
complex .(2.41g, 0.0029 mole) was taken in dry
methanol (80 mL) to which were added fused and
powdered ZnCh (2.72 g, 0.02 mol), and the
mixture was refluxed for 20 hr. The solvent was
removed under vacuo, and the residue obtained
was treated with chilled water, basified with liquor
NH3 and extracted with EtOAc. The extract was
washed with water, dried a'lla2S04)and the organic
solvent removed under vacuo to obtain the desired
gtoduct which was purified over a column of silica
gel, yield: 0.51 g (8.9%). m.p. 220-22° (dec, of
hydrochloride); IR(KBr): 3571-3125 , 1695 em";
IH NMR (CDCh): 0 2.08 (s, 6H, 2' and 6'-CH3),
2.83 (t, J=6 Hz, 2H, -CH2CH2N), 3.37 (s, 3H, -
CH20CH3), 3.58 (s, 3H, NCH3), 3.75 (s, 3H, 10-
OCH3), 4.0 (t, J=6 Hz, 2H, -CH2CH2N), 4.37 (s,
2H, CH20CH3), 5.40 (s, IH, H-l), 6.67 (s, 2H, Ar-
H), 7.0 (s, 2H, Ar-H). Anal. Found: C, 62.58; H,
6.4; N, 9.38; CI, 7.91. Calcd. for C24H28N304CI: C,
62.94; H, 6.16; N, 9.18; CI, 7.74%.
9-Methoxy-l0-hydroxy-2-mesitylimino-3-me-
thyl-3,4-dihydro-2H-pyrimido[ 6,1-a]isoquinolin-
4-one.16. Compound 7 (3.9 g, 0.01 mole) was
taken in benzene (200 mL)and DDQ (2.27 g, (l.01
mole) added to it slowly with stirring. The reaction
mixture was refluxed for 3 hr and the organic
solvent removed under vacuo to obtain a crude
solid, which was treated with chilled water and
acidified with 2N HCI. This acidic solution was
extracted with EtOAc. The aqueous portion was
basified with 15% aqueous NaOH and extracted
with CHCh. The organic extract was washed with
water, dried (Na2S04) and the solvent removed
under vacuo to obtain the desired product which
was purified over a column of basic alumina, yield
0.628 g. The free base was converted into the
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hydrochloride and crystallised from ethanol-ether,
yield 0.605 g (14.2%). m.p. 268-70°. IR(KBr):
1727 ern"; 'H NMR (CDCI,): 82.28 (s, 6H, 2'- and
6'-CH,), 2.45 (s, 3H, 4'-CH,), 3.88 (s, 3H, NCH,),
4.02 (s, 3H, 9-0CH3), 5.8 (s, IH, H-I), 7.03 (d,
J=7 Hz, IH, H-7), 7.2 (d, J=7 Hz, 4H, Ar-H), 8.27
(d, J=7 Hz, 1H, H-6). Anal. Found: C, 63.16; H,
5.43; N, 9.61; CI, 8.07. Ca\cd. for C2JH24




pyrimido[6,1-a)isoquinolin-4-one 17. A mixture
of aldehyde 13 (2.5 g, 0.006 mole) and
hydroxylamine hydrochloride (2.5 g, 0.036 mole)
taken in ethanol (25 mL) and pyridine (2.5 mL,
0.031 mole) was refluxed for 16 hr. The mixture
was stripped off ethanol under vacuo and treated
with water to obtain the desired product which was
filtered, washed with water and dried(Na2S04),
yield 2.53 g (97.68%). m.p. 231-33°: IR(KBr):
3448, 3226, 1724, 1695, 1653cm·l; IH NMR
(CDCI, + DMSO-d6): 8 2.18 (s, 6H, 2' and 6'-CH3),
2.98 (t, ./=6 Hz, 2H, -CH2CH2N)., 3.72 (s, 3H,
NO,1,), 3.80 (s, 3H, IO-OCth), 3.90 (s, 3H, 9-
OCH), 4.13 (t, J=6 Hz, 2H, -CH2CH2N), 5A5 (s,
1H, H-1), 6.70 (d, 2H, Ar-H), 7.4 (s, 2H, Ar-H),
8.0 (s, IH, CH of aldoxime)
9,10-Dimethoxy-2-(2,6-dimethyl-4-cyano)phen-
ylimino )-3-methyl-3,4,6, 7-tetrahydro-2H-pyrimi-
dol6, I-a} isoquinolin-4- one 18. A solution of
oxime 17 (2.5 g, 0.0058 mole) in acetic anhydride
(30 mL, 0.318 mole) was refluxed for 2 hr. On
cooling the desired product crystallised out. It was
filtered and washed with ethanol, yield: 2.06g
(85.83%). m.p. 273-75°: IR(KBr): 2227, 1698 ern";
IH NMR (DMSO-d6): 8 1.85 (s, 6H, 2' and 6'-CH3),
2.73 (t, J=6 Hz, 2H, -CH2CH2N), 3.28 (s, 3H,
NCH3), 3.47 (s, 3H, 10-OCH3), 3.63 (s, 3H, 9-
OCH), 3.76 (t, J=6 Hz, 2H, -CH2CH2N), 5.18 (s,
IH, H-I), 6.75 (d, 2H, Ar-H), 7.38 ( s, 2H, Ar-H).
10-Benzyloxy-9-methoxy-2-mesitylimino-3-me-
thyl-3,4,6,7 -tetrahyd ro-2H-pyrimido[ 6,1-0) isoq ui-
nolin-4-one 25. A mixture of 7 (0.15 g, 0.38
mmole), benzyl bromide (0.06 mL, 0.5 mmole) and
K2CO, (0.08 g, 0.57 mmole) taken in acetone was
refluxed for 2hr. The mixture was cooled treated
with water and extracted with CHCI3 to obtain the
desired product, which was crystallised from
acetone-pet.ether in the form of yellow needles,
yield 0.12 g (65.2%). m.p. 144-460; IR(KBr):
1640,1685 cm'; IH NMR(CDCI,): 82.05 (s, 6H, 2'
and 6'-CH,), 2.35 (s, 3H, 4'-CH,), 2.85 (t, J=6 Hz.
2H, -CH2CH2N), 3.57 (s, 3H, NCH,), 3.9 (s, 3H, 0-
CH1), 4.03(t, J=6 Hz, 2H, -CH2CH2N), 5.05 (s, 2H,
OCH2), 5.47 (s, IH, H-I), 6.7 (s, IH, Ar-H), 6.95
(s, 3H, Ar-H), 7.27 (rn, 5H, Ar-H). Anal. Found: C.
75.27; H, 6.59; N, 8.48. Calcd. for C,oH3I N301: C.
74.84; H, 6.44; N, 8.73%.
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